The growing interest in potent weight management has spurred considerable exploration into groundbreaking treatments. Lately , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist , has exhibited positive results in pat